These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35016907)

  • 1. Apolipoprotein F concentration, activity, and the properties of LDL controlling ApoF activation in hyperlipidemic plasma.
    Morton RE; Mihna D
    J Lipid Res; 2022 Feb; 63(2):100166. PubMed ID: 35016907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ApoF knockdown increases cholesteryl ester transfer to LDL and impairs cholesterol clearance in fat-fed hamsters.
    Morton RE; Liu Y; Izem L
    J Lipid Res; 2019 Nov; 60(11):1868-1879. PubMed ID: 31511396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations of high-density lipoprotein subclasses in hypercholesterolemia and combined hyperlipidemia.
    Jia L; Fu M; Tian Y; Xu Y; Gou L; Tian H; Tian L
    Int J Cardiol; 2007 Sep; 120(3):331-7. PubMed ID: 17166608
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular cloning and expression of lipid transfer inhibitor protein reveals its identity with apolipoprotein F.
    Wang X; Driscoll DM; Morton RE
    J Biol Chem; 1999 Jan; 274(3):1814-20. PubMed ID: 9880564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human low density lipoprotein subfractions separated by gradient gel electrophoresis: composition, distribution, and alterations induced by cholesteryl ester transfer protein.
    Gambert P; Bouzerand-Gambert C; Athias A; Farnier M; Lallemant C
    J Lipid Res; 1990 Jul; 31(7):1199-210. PubMed ID: 2401853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pravastatin on apolipoprotein-specific high density lipoprotein subpopulations and low density lipoprotein subclass phenotypes in patients with primary hypercholesterolemia.
    Cheung MC; Austin MA; Moulin P; Wolf AC; Cryer D; Knopp RH
    Atherosclerosis; 1993 Aug; 102(1):107-19. PubMed ID: 8257447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Markedly elevated lipid transfer inhibitor protein in hypercholesterolemic subjects is mitigated by plasma triglyceride levels.
    Morton RE; Nunes V; Izem L; Quintão E
    Arterioscler Thromb Vasc Biol; 2001 Oct; 21(10):1642-9. PubMed ID: 11597939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma apolipoprotein L concentrations correlate with plasma triglycerides and cholesterol levels in normolipidemic, hyperlipidemic, and diabetic subjects.
    Duchateau PN; Movsesyan I; Yamashita S; Sakai N; Hirano K; Schoenhaus SA; O'Connor-Kearns PM; Spencer SJ; Jaffe RB; Redberg RF; Ishida BY; Matsuzawa Y; Kane JP; Malloy MJ
    J Lipid Res; 2000 Aug; 41(8):1231-6. PubMed ID: 10946010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in plasma lipid and apolipoprotein levels between heparin-induced extracorporeal low-density lipoprotein precipitation (HELP) treatments.
    Lane DM; Alaupovic P; Knight-Gibson C; Dudley VS; Laughlin LO
    Am J Cardiol; 1995 Jun; 75(16):1124-9. PubMed ID: 7762498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between cholesteryl ester transfer activity and high density lipoprotein composition in hyperlipidemic patients.
    Sparks DL; Frohlich J; Lacko AG; Pritchard PH
    Atherosclerosis; 1989 Jun; 77(2-3):183-91. PubMed ID: 2751750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma kinetic behavior in hyperlipidemic subjects of a lipidic microemulsion that binds to low density lipoprotein receptors.
    Maranhão RC; Roland IA; Toffoletto O; Ramires JA; Gonçalves RP; Mesquita CH; Pileggi F
    Lipids; 1997 Jun; 32(6):627-33. PubMed ID: 9208392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of plasma cholesteryl ester transfer activity on the LDL and HDL distribution profiles in normolipidemic subjects.
    Lagrost L; Gandjini H; Athias A; Guyard-Dangremont V; Lallemant C; Gambert P
    Arterioscler Thromb; 1993 Jun; 13(6):815-25. PubMed ID: 8499401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein F: a natural inhibitor of cholesteryl ester transfer protein and a key regulator of lipoprotein metabolism.
    Liu Y; Morton RE
    Curr Opin Lipidol; 2020 Aug; 31(4):194-199. PubMed ID: 32520778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of apolipoprotein F deficiency on high density lipoprotein cholesterol metabolism in mice.
    Lagor WR; Fields DW; Khetarpal SA; Kumaravel A; Lin W; Weintraub N; Wu K; Hamm-Alvarez SF; Drazul-Schrader D; de la Llera-Moya M; Rothblat GH; Rader DJ
    PLoS One; 2012; 7(2):e31616. PubMed ID: 22363685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolism of low density lipoproteins in nephrotic dyslipidemia: comparison of hypercholesterolemia alone and combined hyperlipidemia.
    Vega GL; Toto RD; Grundy SM
    Kidney Int; 1995 Feb; 47(2):579-86. PubMed ID: 7723244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further resolution and comparison of the heterogeneity of plasma low-density lipoproteins in human hyperlipoproteinemias: type III hyperlipoproteinemia, hypertriglyceridemia and familial hypercholesterolemia.
    Luc G; de Gennes JL; Chapman MJ
    Atherosclerosis; 1988 Jun; 71(2-3):143-56. PubMed ID: 3401287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in the lipoprotein distribution of halofantrine are regulated by lipoprotein apolar lipid and protein concentration and lipid transfer protein I activity: in vitro studies in normolipidemic and dyslipidemic human plasmas.
    Wasan KM; Ramaswamy M; McIntosh MP; Porter CJ; Charman WN
    J Pharm Sci; 1999 Feb; 88(2):185-90. PubMed ID: 9950636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of gemfibrozil on very-low-density lipoprotein composition and low-density lipoprotein size in patients with hypertriglyceridemia or combined hyperlipidemia.
    Yang CY; Gu ZW; Xie YH; Valentinova NV; Yang M; Yeshurun D; Quion JA; Gotto AM
    Atherosclerosis; 1996 Sep; 126(1):105-16. PubMed ID: 8879439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma remnant-like particle lipid and apolipoprotein levels in normolipidemic and hyperlipidemic subjects.
    Marcoux C; Tremblay M; Fredenrich A; Jacques H; Krimbou L; Nakajima K; Davignon J; Cohn JS
    Atherosclerosis; 1998 Jul; 139(1):161-71. PubMed ID: 9699904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.